Use of Heterophilic Antibody Blocking Agent (HBT) in Reducing False-Positive hCG Results
Open Access
- 1 July 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 47 (7) , 1332-1333
- https://doi.org/10.1093/clinchem/47.7.1332
Abstract
The USA hCG Reference Service aids physicians in the interpretation of discordant or irregular human chorionic gonadotropin (hCG) results that do not concur with physical findings. The Service has now observed 24 cases of false-positive hCG results (14–571 IU/L). All have been cases erroneously diagnosed with choriocarcinoma or gestational trophoblast disease without demonstrable pregnancy or tumor ( 1)( 2)( 3)( 4). Because of false-positive hCG results, patients have needlessly received chemotherapy, hysterectomy, and/or other surgery. The suspected cause for serum false-positive hCG is the presence of heterophilic antibodies that bind both capture and detection antibodies, effectively bridging them in the same way as the target antigen should in a standard ELISA format.Keywords
This publication has 6 references indexed in Scilit:
- Utility of Commonly Used Commercial Human Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic DiseasesClinical Chemistry, 2001
- The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAsJournal of Immunological Methods, 2000
- False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrationsThe Lancet, 2000
- False-Positive hCG Assay Results Leading to Unnecessary Surgery and Chemotherapy and Needless Occurrences of Diabetes and ComaClinical Chemistry, 1999
- Phantom hCG and Phantom ChoriocarcinomaGynecologic Oncology, 1998
- Heterophilic Antibodies Remain a Problem for the Immunoassay LaboratoryAmerican Journal of Clinical Pathology, 1997